Johns Hopkins Investigators Develop Novel Treatment for T-cell Leukemias and Lymphomas
Johns Hopkins MedicineA novel treatment for leukemias and lymphomas that arise from immune system T cells, developed by investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center and Lustgarten Laboratory, was found to be effective at killing these cancers in mice bearing human T-cell tumors.